The age limit for Wegovy: myth, fact, and what changes at 18

The misconception: that Wegovy has a strict upper age limit

Most people searching this question are not teenagers wondering if they qualify. They are adults in their 50s, 60s or 70s who have been told (by a friend, a forum, or a vague memory of reading something) that GLP-1 medicines are only for younger people. That is not true, and it is worth saying plainly before anything else.

The UK marketing authorisation for Wegovy (semaglutide 2.4 mg) does not include a maximum age. The NHS semaglutide medicines page describes it as suitable for adults, a category that begins at 18 and has no stated ceiling. What older adults do encounter is a more thorough clinical conversation, because kidney function, cardiovascular history, other prescribed medicines and the general complexity of health in later life all need to be weighed carefully. That is good clinical practice, not an age ban.

NICE's recommendation for Wegovy (TA875) similarly addresses adults without restricting by upper age. The clinical trials supporting the licence enrolled participants up to their 70s. Age alone has never been listed as a contraindication in the Wegovy SmPC.

The firm lower limit: under-18s and why it matters

Here the picture is unambiguous. Wegovy is not licensed for weight management in anyone under 18 in the UK. A prescriber cannot lawfully issue a Wegovy prescription for a 16- or 17-year-old under the weight management indication, even if that young person has a BMI that would qualify an adult. This is not a guideline or a soft recommendation, it is a licensing boundary.

There is a separate body of clinical research on semaglutide in adolescents, some of which has been published in peer-reviewed journals. But that evidence base relates to specific study settings and formulations, not to the current UK private prescription of Wegovy. If a family is concerned about a teenager's weight, the right route is their GP, who can refer to a specialist paediatric service.

If you are researching whether there is an age limit for Wegovy on behalf of a young person, the honest answer is yes, there is, and it sits at 18. Our detailed guidance on age and Wegovy eligibility sets out exactly where those boundaries sit and what they mean in practice. Aftercare and lifestyle support through other NHS pathways are the appropriate step below that age.

What older adults should actually consider

For adults over 65 or 70, the question is not whether they are allowed to use Wegovy, it is whether it is the right clinical choice given everything else going on with their health. This is a meaningful distinction.

Prescribers look at a number of things in this group. Kidney function matters because semaglutide is cleared renally, and moderate-to-severe impairment can affect how the medicine behaves. Polypharmacy is relevant: GLP-1 medicines slow gastric emptying, which can shift the absorption timing of other oral medicines taken at the same time. Muscle preservation is another consideration, since weight loss in older adults can include lean mass alongside fat if protein intake and resistance exercise are not actively maintained. None of these are reasons to rule Wegovy out; they are reasons to be precise.

Our clinical team at nume reviews every consultation individually. If questions about age, existing conditions, or other medicines come up during assessment (and they often do) a prescriber works through them personally before any decision is made. The conditions that affect Wegovy eligibility page covers that clinical picture in more detail.

How age fits into the full eligibility picture

Licensing age is the threshold that cannot be crossed. Everything else is clinical judgement. For Wegovy, the licensed eligibility criteria require a BMI of 30 or above, or 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds apply for adults from certain ethnic backgrounds under UK clinical guidance, 2.5 kg/m² lower, as set out in NICE TA875.

Age sits alongside those criteria, not above them. A 72-year-old with a BMI of 34 and hypertension is not excluded by age. A 17-year-old with a BMI of 38 is excluded by age, full stop. The consultation process at nume is designed to work through all of these factors in one place, with the same-day review completed by a GPhC-registered prescriber, not automated software.

If you have questions about how other aspects of your health interact with Wegovy, the practical guidance on starting Wegovy is a useful companion, and if you are weighing up your options, our comparison of Wegovy against other treatments can help you understand how it sits alongside alternatives. The Wegovy overview page covers the broader treatment picture. When treatment is approved, it arrives via DPD the next working day in plain, unmarked packaging, no indication of what is inside.